Treating Heart Valve Disease
CroíValve is an early-stage medical device company developing a novel transcatheter device to repair the tricuspid valve. Its DUO™ System is a catheter-based coaptation device designed to treat tricuspid regurgitation by working in tandem with the native valve, preserving native valve function while restoring coaptation. The company has completed first-in-human implantations and is advancing clinical trials to address a significant unmet need in structural heart disease.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2024
Feb 2022
Mar 2019
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
